Citations

Mayo Clinic

Showing 10 of 108585 citations.

Can Thyroidectomy Be Performed Safely Before a Euthyroid State Is Achieved?
Rachmasari, Kharisa N. , Kawkgi, Omar El

Clinical Thyroidology® | October 5, 2023 | Volume: 35 | Issue: 10 | Pages: 409-412

10.1089/ct.2023;35.409-412 Get It

Factors Associated With Otolaryngologists Performing Tracheotomy
Soliman, Shady , Panuganti, Bharat , Francis, David O. , Klebaner, Dasha, Asturias, Alicia , Alattar, Ali , Wood, Samuel , Terry, M. C. , Bryson, Paul C. , Tipton, Courtney B. , Zhao, Elise E. , Maria, Chloe Santa , Sung, C. Kwang , Lao, Wilson P. , Thompson, Jordan M. , Crawley, Brianna K. , Rosen, Sarah P. , Berezovsky, Anna , Hennesy, Theresa B. , Joseph, Ian T. , Sarhadi, Kamron, Kuhn, Maggie A. , Abdel‐Aty, Yassmeen , Kennedy, Maeve M. , Weissbrod, Philip A. , Abdel-Aty, Yassmeen, Soliman, Shady I , Sung, C K , Weissbrod, Philip A , Pang, John , Terry, Morgan, O'Rourke, Ashli , Grimm, David R. , Kupfer, Robbi A. , Clary, Matthew S. , Lott, David G.

JAMA Otolaryngology–Head & Neck Surgery | October 5, 2023 | Volume: 149 | Issue: 12 | Pages: 1066

10.1001/jamaoto.2023.2698 | PMID 37796485 Get It

ImportanceTracheotomies are frequently performed by nonotolaryngology services. The factors that determine which specialty performs the procedure are not defined in the literature but may be influenced by tracheotomy approach (open vs percutaneous) and other clinicodemographic factors.ObjectiveTo evaluate demographic and clinical characteristics associated with tracheotomies performed by otolaryngologists compared with other specialists and to differentiate those factors from factors associated with use of open vs percutaneous tracheotomy.Design, Setting, and ParticipantsThis multicenter, retrospective cohort study included patients aged 18 years or older who underwent a tracheotomy for cardiopulmonary failure at 1 of 8 US academic institutions between January 1, 2013, and December 31, 2016. Data were analyzed from September 2022 to July 2023.ExposureTracheotomy.Main Outcomes and MeasuresThe primary outcome was factors associated with an otolaryngologist performing tracheotomy. The secondary outcome was factors associated with use of the open tracheotomy technique.ResultsA total of 2929 patients (mean [SD] age, 57.2 [17.2] years; 1751 [59.8%] male) who received a tracheotomy for cardiopulmonary failure (652 [22.3%] performed by otolaryngologists and 2277 [77.7%] by another service) were analyzed. Although 1664 of all tracheotomies (56.8%) were performed by an open approach, only 602 open tracheotomies (36.2%) were performed by otolaryngologists. Most tracheotomies performed by otolaryngologists (602 of 652 [92.3%]) used the open technique. Multivariable regression analysis revealed that self-reported Black race (odds ratio [OR], 1.89; 95% CI, 1.52-2.35), history of neck surgery (OR, 2.71; 95% CI, 2.06-3.57), antiplatelet and/or anticoagulation therapy (OR, 1.74; 95% CI, 1.29-2.36), and morbid obesity (OR, 1.54; 95% CI, 1.24-1.92) were associated with greater odds of an otolaryngologist performing tracheotomy. In contrast, history of neck surgery (OR, 1.36; 95% CI, 0.96-1.92), antiplatelet and/or anticoagulation therapy (OR, 0.80; 95% CI, 0.56-1.14), and morbid obesity (OR, 0.94; 95% CI, 0.74-1.19) were not associated with undergoing open tracheotomy when performed by any service, and Black race (OR, 0.56; 95% CI, 0.44-0.71) was associated with lesser odds of an open approach being used. Age-adjusted Charlson Comorbidity Index score greater than 4 was associated with greater odds of both an otolaryngologist performing tracheotomy (OR, 1.26; 95% CI, 1.03-1.53) and use of the open tracheotomy technique (OR, 1.48, 95% CI, 1.21-1.82).Conclusions and RelevanceIn this study, otolaryngologists were significantly more likely than other specialists to perform a tracheotomy for patients with history of neck surgery, morbid obesity, and ongoing anticoagulation therapy. These findings suggest that patients undergoing tracheotomy performed by an otolaryngologist are more likely to present with complex and challenging clinical characteristics.
Initial interactions with the FDA on developing a validation dataset as a medical device development tool
Hart, Steven N. , García, Víctor , Dudgeon, Sarah , Hanna, Matthew G. , Li, Xiaoxian , Blenman, Kim , Elfer, Katherine , Salgado, Roberto , Saltz, Joel , Gupta, Rajarsi , Hytopoulos, Evangelos, Larsimont, Denis , Lennerz, Jochen K. , Hart, Steven N , Blenman, Kim Rm , Saltz, Joel H , Gupta, Rajarsi R , Gallas, Brandon D , Lennerz, Jochen , Ly, Amy

The Journal of Pathology | October 5, 2023 | Volume: 261 | Issue: 4 | Pages: 378-384

10.1002/path.6208 | PMID 37794720 Get It

AbstractQuantifying tumor‐infiltrating lymphocytes (TILs) in breast cancer tumors is a challenging task for pathologists. With the advent of whole slide imaging that digitizes glass slides, it is possible to apply computational models to quantify TILs for pathologists. Development of computational models requires significant time, expertise, consensus, and investment. To reduce this burden, we are preparing a dataset for developers to validate their models and a proposal to the Medical Device Development Tool (MDDT) program in the Center for Devices and Radiological Health of the U.S. Food and Drug Administration (FDA). If the FDA qualifies the dataset for its submitted context of use, model developers can use it in a regulatory submission within the qualified context of use without additional documentation. Our dataset aims at reducing the regulatory burden placed on developers of models that estimate the density of TILs and will allow head‐to‐head comparison of multiple computational models on the same data. In this paper, we discuss the MDDT preparation and submission process, including the feedback we received from our initial interactions with the FDA and propose how a qualified MDDT validation dataset could be a mechanism for open, fair, and consistent measures of computational model performance. Our experiences will help the community understand what the FDA considers relevant and appropriate (from the perspective of the submitter), at the early stages of the MDDT submission process, for validating stromal TIL density estimation models and other potential computational models. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
Histiocytic Sarcoma Treated with Pembrolizumab: A Case Report and Literature Review
Huff, Daniel , Ensign, Shannon P. Fortin , Ryan, Margaret , Palmer, Jeanne , Fortin Ensign, Shannon, Ryan, Margaret S, Ensign, Shannon P. Fortin , Muñoz, Javier

Journal of Immunotherapy and Precision Oncology | October 5, 2023 | Volume: 6 | Issue: 4 | Pages: 198-202

10.36401/jipo-23-11 | PMID 38143950 Get It

ABSTRACT Histiocytic sarcoma (HS) is a rare hematologic malignancy that has historically been treated with lymphoma-based regimens with a median survival of 6 months. We describe a case of a 51-year-old woman who presented with acute back pain and cord compression. She was diagnosed with HS with diffuse skeletal lesions and high expression of programmed death ligand 1 (PD-L1). She was subsequently treated with chemotherapy plus off-label use of pembrolizumab followed by allogeneic stem cell transplantation. Ultimately, the patient died in the setting of progression of disease 17 months after her stem cell transplantation and 26 months after her diagnosis. This article also presents a literature review of cases of HS treated with programmed death ligand inhibition.
The role of osteopathic principles and practice in upper extremity injuries of the overhead athlete
Luigi, Arthur Jason De , De Luigi, Arthur Jason

Journal of Osteopathic Medicine | October 5, 2023 | Volume: 124 | Issue: 1 | Pages: 1-4

10.1515/jom-2023-0145 | PMID 37796149 Get It

Impact of smoking on outcomes following endovascular therapy for acute ischemic stroke: A systematic review and meta-analysis
Kobeissi, Hassan , Ghozy, Sherief , Turfe, Bilal, Amoukhteh, Melika , Kadirvel, Ramanathan , Brinjikji, Waleed , Kallmes, David F. , Kallmes, David F , Ghozy, Sherief , Kobeissi, Hassan , Rabinstein, Alejandro A.

Interventional Neuroradiology | October 5, 2023 | Volume: 32 | Issue: 3 | Pages: 849-854

10.1177/15910199231206100 | PMID 37796821 Get It

Background Smoking represents a leading risk factor for acute ischemic stroke (AIS). Previous literature has described a “smoking paradox”, wherein smokers experience better outcomes following intravenous thrombolysis for AIS. It is unclear whether such a phenomenon exists in smokers undergoing endovascular therapy (EVT) for AIS. To assess outcomes in smokers following EVT for AIS, we conducted a systematic review and meta-analysis. Methods Following the PRISMA guidelines, a systematic literature review of the English language literature was conducted using PubMed, Embase Web of Science, and Scopus. Outcomes of interest included 90-day modified Rankin Scale (mRS) 0–2, thrombolysis in cerebral infarction (TICI) score 2b-3, symptomatic intracranial hemorrhage (sICH), and mortality. We calculated mean difference (MD), pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CI). Results Eight studies with 2633 patients comprised our analysis. On average, smokers were 10.14 years (MD = 10.14, [95% CI = −14.49 to −5.79], P-value < 0.001) younger than non-smokers. Smokers achieved mRS 0–2 (OR = 1.82, [95% CI, 1.34–2.48], P-value < 0.001) and TICI 2b-3 (OR = 1.61, [95% CI, 1.19–2.19], P-value = 0.002) at a higher rate than non-smokers. sICH rates were comparable between smokers and non-smokers (OR = 1.07, [95% CI, 0.62–1.85], P-value = 0.81). Smokers had a lower rate of 90-day mortality than non-smokers (OR = 0.54, [95% CI, 0.41–0.71], P-value < 0.001). Conclusions In this meta-analysis of eight studies, we found that smokers with AIS undergoing EVT experienced better 90-day outcomes and higher rates of TICI 2b-3. This may be due to baseline differences between smokers and non-smokers, but future studies should explore alternative reasons that could explain this relationship between smoking and AIS treated with EVT.
Locally Low-Rank Denoising of Multi-Echo Functional MRI Data With Application in Resting-State Analysis
Meyer, Nolan , Ahmed, Zaki , In, Myung‐Ho , Shu, Yunhong , Trzasko, Joshua D. , Meyer, Nolan K , In, Myung-Ho , Kang, Daehun , Huston, John , Bernstein, Matt A.

Topics in Magnetic Resonance Imaging | October 5, 2023 | Volume: 32 | Issue: 5 | Pages: 37-49

10.1097/rmr.0000000000000307 | PMID 37796647 Get It

Abstract: Objectives: Locally low-rank (LLR) denoising of functional magnetic resonance imaging (fMRI) time series image data is extended to multi-echo (ME) data. The proposed method extends the capabilities of non-physiologic noise suppression beyond single-echo applications with a dedicated ME algorithm. Materials and Methods: Following an institutional review board (IRB) approved protocol, resting-state fMRI data were acquired in 7 healthy subjects. A compact 3T scanner enabled whole-brain acquisition of multiband ME fMRI data at high spatial resolution (1.4 × 1.4 × 2.8 mm3) with a 1810 ms repetition time (TR). Image data were denoised with ME-LLR preceding functional processing. The results of connectivity maps generated from denoised data were compared with maps generated with equivalent processing of non-denoised images. To assess ME-LLR as a method to reduce scan time, comparisons were made between maps computed from image data with full and retrospectively truncated durations. Assessments were completed with seed-based connectivity analyses using echo-combined image data. In a feasibility assessment, nondenoised and denoised full-duration echo-combined data were equivalently processed with independent component analysis (ICA) and compared. Results: ME-LLR denoising yielded strengthened resting-state network connectivity maps after nuisance regression and seed-based connectivity analysis. In assessing ME-LLR as a scan reduction mechanism, maps generated from denoised data at half scan time showed comparable quality with maps generated from full-duration, non-denoised data, at both single subject and group levels. ME-LLR substantially increased temporal signal-to-noise ratio (tSNR) for image data respective to each individual echo and for image data after nuisance regression. Among echo-specific image volumes, increases in tSNR yielded by ME-LLR were most pronounced for image data with the longest echo time and thereby lowest SNR. ICA showed resting-state networks consistently identified between non-denoised and denoised data, with clearer demarcation of networks for ME-LLR. Conclusions: ME-LLR is demonstrated to suppress non-physiologic noise, enhance functional connectivity map quality, and could potentially facilitate scan time reduction in ME-fMRI.
Leave No One Behind
Coleman, Dawn M. , Rasmussen, Todd E.

Annals of Surgery | October 5, 2023 | Volume: 279 | Issue: 1 | Pages: 11-12

10.1097/sla.0000000000006115 | PMID 37795628 Get It

Impairment of Endothelial Function by Cigarette Smoke and e-Cigarette Aerosol Requires RAGE
Han, Daniel D , Rao, Poonam , Qiu, Huiliang , Navabzadeh, Mina , Wang, Xiaoyin , Goyal, Natasha , Mohammadi, Leila , Huang, Abel , Perez, Bryanna G. , Schick, Suzaynn F. , Springer, Matthew L. , Wang, Xiaoyin

Arteriosclerosis, Thrombosis, and Vascular Biology | October 5, 2023 | Volume: 43 | Issue: 12 | Pages: 2369-2371

10.1161/atvbaha.123.319514 | PMID 37795616 Get It

Faculty Opinions recommendation of An immune cell atlas reveals the dynamics of human macrophage specification during prenatal development.
Wu, Long‐Jun

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | October 5, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.742779639.793600945 Get It